Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Is Dropping This Week


Shares of Moderna (NASDAQ: MRNA) were dropping 15.2% this week as of market close on Thursday, based on data from S&P Global Market Intelligence. The only news from the company in recent days were announcements about participation in two healthcare conferences and the dosing of the first patient in the phase 1 study of its Epstein-Barr Virus (EBV) vaccine candidate. 

Did these announcements cause the vaccine stock to fall? No. Instead, the primary issue for Moderna right now is that investors appear to be increasingly pessimistic about future demand for COVID-19 vaccines. 

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments